The resumption of trading for G1 Therapeutics shares typically leads to a neutral short-term impact on the stock price. However, the news could result in increased trading volume and volatility as investors and traders respond to the resumption. The importance is rated high due to the direct effect on the ability to trade the shares, and confidence is high as the information is straightforward and directly impacts the stock.